Clinical Trial Update: 99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 99mTc-anti-TNF-alpha scintigraphy for assessing inflammatory activity in psoriatic arthritis and arthritis; current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Psoriatic Arthritis

Drugs mentioned

• 99mTc-anti-TNF-alpha scintigraphy (Technetium-99m labeled anti-TNF-alpha tracer)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Psoriatic Arthritis, Arthritis | Phase 2 | Status: UNKNOWN